These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22322595)

  • 1. Endothelin-converting enzyme-1 actions determine differential trafficking and signaling of corticotropin-releasing factor receptor 1 at high agonist concentrations.
    Hasdemir B; Mahajan S; Bunnett NW; Liao M; Bhargava A
    Mol Endocrinol; 2012 Apr; 26(4):681-95. PubMed ID: 22322595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin-converting enzyme-1 regulates endosomal sorting of calcitonin receptor-like receptor and beta-arrestins.
    Padilla BE; Cottrell GS; Roosterman D; Pikios S; Muller L; Steinhoff M; Bunnett NW
    J Cell Biol; 2007 Dec; 179(5):981-97. PubMed ID: 18039931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desensitization of human CRF2(a) receptor signaling governed by agonist potency and βarrestin2 recruitment.
    Hauger RL; Olivares-Reyes JA; Braun S; Hernandez-Aranda J; Hudson CC; Gutknecht E; Dautzenberg FM; Oakley RH
    Regul Pept; 2013 Sep; 186():62-76. PubMed ID: 23820308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin-converting enzyme-1 regulates trafficking and signalling of the neurokinin 1 receptor in endosomes of myenteric neurones.
    Pelayo JC; Poole DP; Steinhoff M; Cottrell GS; Bunnett NW
    J Physiol; 2011 Nov; 589(Pt 21):5213-30. PubMed ID: 21878523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin-converting enzyme 1 degrades neuropeptides in endosomes to control receptor recycling.
    Roosterman D; Cottrell GS; Padilla BE; Muller L; Eckman CB; Bunnett NW; Steinhoff M
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11838-43. PubMed ID: 17592116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist-biased trafficking of somatostatin receptor 2A in enteric neurons.
    Zhao P; Canals M; Murphy JE; Klingler D; Eriksson EM; Pelayo JC; Hardt M; Bunnett NW; Poole DP
    J Biol Chem; 2013 Sep; 288(36):25689-25700. PubMed ID: 23913690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotensin-induced proinflammatory signaling in human colonocytes is regulated by β-arrestins and endothelin-converting enzyme-1-dependent endocytosis and resensitization of neurotensin receptor 1.
    Law IK; Murphy JE; Bakirtzi K; Bunnett NW; Pothoulakis C
    J Biol Chem; 2012 Apr; 287(18):15066-75. PubMed ID: 22416137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin-converting enzyme 1 and β-arrestins exert spatiotemporal control of substance P-induced inflammatory signals.
    Jensen DD; Halls ML; Murphy JE; Canals M; Cattaruzza F; Poole DP; Lieu T; Koon HW; Pothoulakis C; Bunnett NW
    J Biol Chem; 2014 Jul; 289(29):20283-94. PubMed ID: 24898255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endosomal endothelin-converting enzyme-1: a regulator of beta-arrestin-dependent ERK signaling.
    Cottrell GS; Padilla BE; Amadesi S; Poole DP; Murphy JE; Hardt M; Roosterman D; Steinhoff M; Bunnett NW
    J Biol Chem; 2009 Aug; 284(33):22411-22425. PubMed ID: 19531493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of corticotropin releasing factor 1alpha receptor endocytosis and trafficking by beta-arrestins and Rab GTPases.
    Holmes KD; Babwah AV; Dale LB; Poulter MO; Ferguson SS
    J Neurochem; 2006 Feb; 96(4):934-49. PubMed ID: 16412099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin-converting enzyme-1 degrades internalized somatostatin-14.
    Roosterman D; Kempkes C; Cottrell GS; Padilla BE; Bunnett NW; Turck CW; Steinhoff M
    Endocrinology; 2008 May; 149(5):2200-7. PubMed ID: 18276747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recycling and resensitization of the neurokinin 1 receptor. Influence of agonist concentration and Rab GTPases.
    Roosterman D; Cottrell GS; Schmidlin F; Steinhoff M; Bunnett NW
    J Biol Chem; 2004 Jul; 279(29):30670-9. PubMed ID: 15128739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticotropin-releasing factor, urocortin 1, and their receptors in the mouse spinal cord.
    Korosi A; Kozicz T; Richter J; Veening JG; Olivier B; Roubos EW
    J Comp Neurol; 2007 Jun; 502(6):973-89. PubMed ID: 17444496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urocortin 1 modulates immunosignaling in a rat model of colitis via corticotropin-releasing factor receptor 2.
    Chang J; Adams MR; Clifton MS; Liao M; Brooks JH; Hasdemir B; Bhargava A
    Am J Physiol Gastrointest Liver Physiol; 2011 May; 300(5):G884-94. PubMed ID: 21330446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of N-terminal domains for corticotropin-releasing factor (CRF) receptor-ligand interactions.
    Klose J; Fechner K; Beyermann M; Krause E; Wendt N; Bienert M; Rudolph R; Rothemund S
    Biochemistry; 2005 Feb; 44(5):1614-23. PubMed ID: 15683245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology.
    Bangasser DA; Curtis A; Reyes BA; Bethea TT; Parastatidis I; Ischiropoulos H; Van Bockstaele EJ; Valentino RJ
    Mol Psychiatry; 2010 Sep; 15(9):877, 896-904. PubMed ID: 20548297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboxyl-terminal and intracellular loop sites for CRF1 receptor phosphorylation and beta-arrestin-2 recruitment: a mechanism regulating stress and anxiety responses.
    Oakley RH; Olivares-Reyes JA; Hudson CC; Flores-Vega F; Dautzenberg FM; Hauger RL
    Am J Physiol Regul Integr Comp Physiol; 2007 Jul; 293(1):R209-22. PubMed ID: 17363685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation-induced abnormalities in the subcellular localization and trafficking of the neurokinin 1 receptor in the enteric nervous system.
    Poole DP; Lieu T; Pelayo JC; Eriksson EM; Veldhuis NA; Bunnett NW
    Am J Physiol Gastrointest Liver Physiol; 2015 Aug; 309(4):G248-59. PubMed ID: 26138465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agonist bias and agonist-dependent antagonism at corticotrophin releasing factor receptors.
    Tasma Z; Wills P; Hay DL; Walker CS
    Pharmacol Res Perspect; 2020 Jun; 8(3):e00595. PubMed ID: 32529807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urocortin 1 inhibits guinea pig gallbladder contractility in vitro via corticotropin-releasing factor receptor 2.
    Abd El-Aziz SM; Abdel-Wahab BA
    Can J Physiol Pharmacol; 2011 Nov; 89(11):783-91. PubMed ID: 22007876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.